Longevity Sprint is the world’s first accelerator dedicated to the longevity and silver economy. Scalable IP, government backing, biotech clusters and a large underserved preventative-health market are moving the region from sick care to health care — and ventures built inside that ecosystem compound faster than anything standalone. We land global longevity IP in Asia, and take Asia’s breakthroughs to the world.
Longevity Sprint 是全球首个专注长寿与银发经济的加速器。可规模化的知识产权、政府支持、生物科技集群，以及庞大而未被满足的预防性健康需求，正推动区域从疾病治疗走向健康管理——依托生态构建的创业公司，其复利速度快于任何单打独斗的模式。我们把全球长寿技术落地亚洲，也把亚洲的突破带向世界。
What We Do
我们的服务
Anchoring the inevitable transition toward a proactive, ageless society.
锚定迈向主动健康、无龄社会的必然趋势。
Our deal flow is driven by targeted events, founder and investor referrals, and a strong network built over a decade in tech and medical ventures — giving us unparalleled access to competitive rounds ahead of the market.
我们的项目源自精准的行业活动、创始人与投资人推荐，以及深耕科技与医疗创投十余年积累的强大网络——使我们能先于市场，触达最具竞争力的融资轮次。
Landing Acceleration
落地加速服务
AGVC builds solutions that drive healthspan improvement from pharma, universities, and biotech — and develops them faster and more efficiently by leveraging our cross-border acceleration program and co-investment network. We apply our collective power to build successful companies around brilliant ideas.
AGVC 携手制药企业、高校与生物科技机构，共同打造推动健康寿命提升的解决方案，并依托跨境加速计划与联合投资网络，更快、更高效地推进其发展。我们汇聚集体力量，围绕卓越创意打造成功企业。
- Corporate structuring, organisation design & strategy planning
- Ecosystem partnering — research institutes, hospital groups & CROs
- Buyer, manufacturer & distributor matching
- IP structuring, patent liaison & R&D co-development framing
- Accounting, tax planning & reporting systems
- Funding support & grant facilitation
- 集团架构设计、组织规划及战略布局
- 生态对接——研究院、医院集团及CRO
- 买家、制造商及分销商匹配对接
- 知识产权架构、专利协调及研发合作框架
- 会计核算、税务筹划及财务报告体系搭建
- 资金支持与资助统筹
Local CDMO & Manufacturing Partnering
本地CDMO及制造合作
For biotech, pharma, and MedTech founders with validated IP, we identify and broker access to CDMOs and manufacturing partners.
针对拥有经验证知识产权的生物科技、制药及医疗器械创始人，我们在香港、大湾区及东南亚识别并对接合适的CDMO及制造合作伙伴。
- CDMO identification and matchmaking
- Manufacturing and supply agreement negotiation
- IP out-licensing to regional pharma, MedTech & manufacturing partners
- Asset licensing deal structuring and milestone architecture
- GMP readiness, quality systems & regulatory filing support
- R&D co-development with local academic and institute partners
- 香港、广东及东盟CDMO识别与精准匹配
- 制造及供应协议谈判
- 知识产权向区域制药、医疗器械及制造伙伴的授权转让
- 资产授权交易架构及里程碑体系设计
- GMP合规准备、质量体系及法规申报支持
- 与本地学术机构及研究院联合研发合作
Venture Building & Operational Integration
创投孵化与运营整合
For companies that need more than advisory — we embed operationally, building end-to-end commercial infrastructure from upstream procurement and manufacturing through to downstream market delivery across Asia.
针对需要深度支持的企业——我们深度嵌入运营，构建从上游采购、制造到下游亚洲市场交付的全链路商业基础设施。
- Embedded operational leadership — External COO model
- End-to-end value chain: procurement, manufacturing, distribution
- Strategic alliances with industry, academic institutions & public sector
- Product commercialisation across health-tech, medical device & supplement verticals
- Co-build ventures alongside founding teams from pre-incorporation
- 嵌入式运营领导团队——外部COO模式
- 全链路价值链管理：采购、制造、分销
- 与产业界、学术机构及公共部门建立战略联盟
- 健康科技、医疗器械及营养补充品领域产品商业化
- 与创始团队联合孵化，从公司注册前阶段全程参与
- 生态圈引荐：香港科技园、数码港、InnoHK创新集群
Research
研究
Forthcoming
即将发布
Our first annual report on aging science, capital formation and company building across Asia-Pacific. It covers what is actually being licensed and funded in the region — institutional pipelines, financing structures, regulatory routes and the reference-data question — rather than another projection of the demographic curve.
Written for the ecosystem rather than for a portfolio, so university, institute and clinical partners can contribute without a commercial relationship.
我们的首份年度报告，覆盖亚太地区的衰老科学、资本形成与公司创建。报告关注区域内真实发生的许可与融资——机构技术管线、融资结构、监管路径，以及参照数据问题——而不是又一次对人口曲线的预测。
报告面向整个生态而非某一投资组合撰写，高校、研究院与临床伙伴可在没有商业关系的前提下参与。
- University groups and technology transfer offices with primary licensing data
- Clinical centres and cohort holders working on aging biomarkers
- Insurers and health systems running preventative pilots
- Investors and operators willing to co-author a chapter
- 拥有一手许可数据的高校课题组与技术转移办公室
- 从事衰老生物标志物研究的临床中心与队列持有方
- 正在试点预防性健康项目的保险公司与医疗体系
- 愿意共同撰写章节的投资人与从业者
Register your interest via the contact form and we will send the report on release. Tell us in the message if you would like to contribute a chapter or data.
通过联系表格登记，报告发布时我们会第一时间发送。如希望共同撰写章节或提供数据，请在留言中说明。
Ecosystem
生态伙伴
Supporting partners and organisations
支持伙伴与合作机构
